1yr
Breast Cancer Connect
1yr
Breast cancer organoids derived from patients: A platform for tailored drug screening - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37709150/
Breast cancer stands as the most prevalent and heterogeneous malignancy affecting women globally, posing a substantial health concern. Enhanced comprehension of tumor pathology and the development of novel therapeutics are...
This review highlights the potential of breast cancer organoids as advanced in vitro models, emphasizing their advantages in precision medicine, drug innovation, and disease modeling through enhanced tissue mimicry and genetic stability.
1yr
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39059194/
Accurate information about locoregional treatments in breast cancer neoadjuvant systemic therapy (NST) trials is vital to support surgical decision-making and allow meaningful interpretation of long-term oncological outcomes. This systematic review...
This systematic review highlights poor and inconsistent reporting of locoregional treatment outcomes in breast cancer neoadjuvant systemic therapy studies, emphasizing the need for a core outcome set and reporting guidelines.
1yr
Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39216449/
Breast cancer (BC) is one of the most frequently diagnosed cancers in women. Chemotherapy continues to be the treatment of choice for clinically combating it. Nevertheless, the chemotherapy process is...
This article reviews multidrug resistance (MDR) mechanisms in breast cancer and explores nano-drug delivery systems (NDDS) as potential solutions to improve chemotherapy efficacy and overcome MDR challenges.
1yr
Cryotherapy in the Treatment of Early-Stage Breast Cancer
Source : https://pubmed.ncbi.nlm.nih.gov/39328333/
Breast cancer is one of the most common malignancies, affecting millions of people worldwide annually. The treatment paradigm for early-stage breast cancer is in flux. The focus is now on...
Cryoablation shows promise as a minimally invasive treatment for early-stage breast cancer, with ongoing trials crucial for assessing its safety and effectiveness compared to traditional surgical approaches.